At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Microprobe glucose sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes
In Brief
A clinical study evaluating Microprobe glucose sensor for Diabetes Mellitus. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of the study is to assess the safety and efficacy of the Imperial College Microprobe Array Continuous Glucose Sensor in healthy volunteers and in subjects with type 1 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 2013
Enrollment StartNov 2013
Primary CompletionJun 2017
Study CompletionJun 2018
TodayJul 2026
First PostedJul 25, 2013
Enrollment StartNov 1, 2013
Primary CompletionJun 1, 2017
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.9 years ago
Interventions
Microprobe glucose sensordevice
Assessment of safety and accuracy of a novel continuous glucose monitor based on microprobe technology.